Besides maintaining an active clinical practice focused on the management of patients with malignancies of the thoracic cavity, Halmos oversees the thoracic clinical trials program at Columbia University. He also runs a translational research laboratory investigating novel ways to overcome resistance to conventional as well as targeted therapeutics. He is chair of the Cancer Institutional Review Board of Columbia University. Halmos holds an MD from Semmelweis Medical University, Hungary.